FrancophonIA/ELRC3.0 huggingface dataset:
English: In 1986 he joined the University of Bordeaux and was involved in various research areas in public health, including epidemiology, clinical research, pharmacovigilance, tropical and infectious diseases, health economy and health education.
Estonian: 1986. aastal asus ta tööle Bordeaux Ülikooli ja tegeles rahvatervise alase uurimistööga, sealhulgas epidemioloogia, kliiniliste uuringute, ravimiohutuse järelevalve,
English: Revised guideline on specifications: test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products
Estonian: test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products
English: Enhancement of the activity-based budgeting system
Estonian: tegevusepõhise eelarvestussüsteemi täiustamine;
English: Objective:
Estonian: Eesmärk:
English: Policy for the transmission of PhVWP Recommendations and Assessment Reports for mutually recognised and purely nationally authorised products to marketing authorisation holders
Estonian: Reports for mutually recognised and purely nationally authorised products to marketing authorisation holders
English: 100 % of fees for protocol assistance
Estonian: 100% protseduurilise abi tasudest;
English: Development of a new document with PEG (Paediatrics Working Party)
Estonian: Uue dokumendi väljatöötamine koos pediaatria töörühmaga
English: In 1998 he was coordinator-director for the creation of the Spanish Medicines Agency and executive director of the Spanish Medicines Agency from 1999 to 2000.
Estonian: 1998. aastal oli ta Hispaania Ravimiameti asutamisel direktor koordineerimise alal ja aastail 1999
English: 2.7 Herbal medicinal products
Estonian: 2.7 Taimsed ravimid
English: Infrastructure Services at the EMEA
Estonian: EMEA infrastruktuuriteenused
English: Preparatory work in the area of procedures to be established in relation to the provision to Member States and European institutions of the best scientific opinion on questions related to herbal medicinal products, as well as to the adoption of opinions at the request of the Committee for Medicinal Products for Human Use
Estonian: menetluste ettevalmistamine, mis tuleb kehtestada parima teadusliku arvamuse andmiseks liikmesriikidele ja Euroopa institutsioonidele taimsete ravimitega seotud küsimustes, samuti arvamuste vastuvõtmiseks inimtervishoius kasutatavate ravimite komitee taotlusel; registreerimistaotluse sisule esitatavate nõuete selgitamine.
English: To implement the new legislative requirements and increase the quality of assessment of such applications and adhere to regulatory timelines
Estonian: uute õigusaktide nõuete täitmine ja nende taotluste hindamise kvaliteedi tõstmine ja kehtestatud tähtaegadest kinnipidamine.
English: He was appointed head of sector for quality of medicines in January 2001.
Estonian: 2001. aasta jaanuaris määrati ta ravimite kvaliteedi sektori juhatajaks.
English: Implementation of a pilot programme for parallel scientific advice with the US Food and Drug Administration and monitoring of its effectiveness
Estonian: USA Toidu- ja Ravimiametiga koos pakutava paralleelse teadusnõustamise katseprogrammi elluviimine ja järelevalve selle tulemuslikkuse üle;
English: Implementation of an action plan for revision of the sampling and testing programme for centrally authorised products, in cooperation with EDQM, to streamline activities and focus resources taking a risk-based approach.
Estonian: Tsentraliseeritud müügiloaga ravimite proovivõtmis- ja testimisprogrammi muutmise tegevuskava rakendamine koostöös Euroopa ravimikvaliteedi direktoraadiga (EDQM), et tõsta tegevuse efektiivsust ja koondada ressursse, lähtudes riskipõhisest lähenemisviisist.
English: The EMEA will provide support to workshops with stakeholders, in particular with academic research organisations, organised at the initiative of the COMP and CHMP, on new scientific and methodological aspects.
Estonian: EMEA osutab abi seminaride korraldamisel huvirühmadega, eelkõige akadeemiliste uurimisorganisatsioonidega, mida algatavad uute teadusalaste ja metoodiliste aspektide kohta harva kasutatavate ravimite komitee ja inimtervishoius kasutatavate ravimite komitee.
English: New applications for veterinary medicines received/forecast (Input)
Estonian: Uued taotlused veterinaarravimite kohta laekunud/prognoositud (laekumised)
English: Annex 4 EMEA contact points
Estonian: 4. lisa EMEA kontaktpunktid
English: Further strengthening and maintenance of the quality assurance system in relation to the management of procedures and CHMP activities
Estonian: kvaliteedi tagamise süsteemi edasine tugevdamine ja alalhoidmine seonduvalt menetluste ja inimtervishoius kasutatavate ravimite komitee juhtimisega;
English: To provide timely and understandable product information to patients and healthcare professionals
Estonian: õigeaegse ja arusaadava ravimiteabe pakkumine patsientidele ja tervishoiutöötajatele.
English: Specialist in internal medicine and clinical pharmacology.
Estonian: Spetsialist sisehaiguste ja kliinilise farmakoloogia alal.
English: Martin HARVEY ALLCHURCH Direct telephone (44-20) 74 18 84 27 E-mail: press@emea.eu.int
Estonian: Martin HARVEY ALLCHURCH Otsetelefon (44-20) 74 18 84 27 E-post: press@emea.eu.int
English: The performance indicator for this objective is the percentage of responses provided within 14 days.
Estonian: Selle eesmärgi saavutamise näitaja on 14 päeva jooksul antud vastuste protsent.
English: He joined the EMEA in August 1996 as head of sector for regulatory affairs and pharmacovigilance and was appointed head of the Human Medicines Evaluation Unit in September 2000.
Estonian: EMEA-s asus ta tööle 1996. aasta augustis regulatiivküsimuste ja ravimiohutuse järelevalve sektori juhatajana ja 2000. aasta septembris määrati ta inimtervishoius kasutatavate ravimite hindamise üksuse juhatajaks.
English: He was director of medical affairs of the French pharmaceutical trade association from 1985 to 1993 and returned to industry until 1994.
Estonian: Ta oli aastail 1985-1993 Prantsusmaa Farmaatsialiidu meditsiinidirektor ja pöördus farmaatsiatööstusesse tööle tagasi kuni
English: 15 December
Estonian: 15. detsember
English: Education: Bachelor of Arts in languages and linguistics at the University of East Anglia and postgraduate degree in librarianship and information science at the University of Wales.
Estonian: Haridus: East Anglia Ülikooli bakalaureusekraad keelte ja keeleteaduse alal ja raamatukogunduse ja informaatika kraad Walesi Ülikoolist.
English: Position paper on the non-clinical safety studies to support clinical trials, with a single low dose of a compound
Estonian: Position paper on the non-clinical safety studies to support clinical trials,
English: Education: PhD in microbiology from the University of Lyon.
Estonian: Haridus: PhD mikrobioloogia alal Lyoni Ülikoolist.
English: Conduct joint planning to manage the resource implications arising from the new pharmaceutical legislation, the advent of new technologies and the increase in the number of scientific resource providers
Estonian: Põhilised algatused selle eesmärgi saavutamiseks: ühine planeerimine uute farmaatsiaalaste õigusaktide, uute tehnoloogiate ja teadusalaste ressursside arvukamate pakkujate mõju tõttu ressursside haldamisele;
English: In 1995 she joined the French Medicines Agency as head of unit for pharmaco-toxico-clinical assessment.
Estonian: 1995. aastal asus ta tööle Prantsusmaa Ravimiametis farmako toksiko-kliinilise hindamise üksuse juhatajana.
English: Orphan medicinal products are intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions affecting not more than five in 10,000 persons in the European Community, or where for economic reasons such medicines would not be developed without incentives.
Estonian: Harva kasutatavad ravimid on kavandatud Euroopa Ühenduses (edaspidi “ühendus”) mitte enam kui viit inimest kümnest tuhandest mõjutava eluohtliku või jäävalt invaliidistava haigusseisundi diagnoosimiseks, vältimiseks või raviks; samuti on need ravimid, mida majanduslikel põhjustel ilma soodustusteta välja ei töötataks.
English: As a result of the initiatives in the area of transparency and communication, patients, healthcare professionals, academia, learned societies, the pharmaceutical industry and other stakeholders will have faster, easier access to a wider range of information regarding the activities of the Agency and the network.
Estonian: Läbipaistvuse ja kommunikatsiooniga seotud algatuste tulemusena on mitmesugune teave ameti ja võrgustiku tegevuse kohta patsientidele, tervishoiutöötajatele, akadeemilistele ringkondadele, õpetatud seltsidele, farmaatsiatööstusele ja teistele huvirühmadele kiiremini ja kergemini kättesaadav.
English: He served on the management board of the French National Agency for Health Evaluation and Hospital Accreditation (ANAES) from 2000 to 2004, and on its executive committee from 2002 to 2004.
Estonian: Haiglate Akrediteerimise Ameti (ANAES) haldusnõukogus ja aastail 2002-2004 selle täitevkomitees.
English: Career to date: Worked as a clinical endocrinologist in a French hospital until 1987 and then joined the directorate of pharmacy at the French Ministry of Health.
Estonian: Senine teenistuskäik: Töötas kuni 1987. aastani Prantsusmaal haiglas kliinilise endokrinoloogina ja asus siis tööle Prantsusmaa Tervishoiuministeeriumi farmaatsia direktoraati.
English: The agreed action plan for revision of the programme requires an update of all documentation and SOPs at both the EMEA and EDQM.
Estonian: Programmi läbivaatamiseks kokkulepitud tegevuskava kohaselt tuleb uuendada nii EMEA-s kui ka
English: Education: Qualified pharmacist and degree in medicine and surgery from the University of Barcelona, as well as postgraduate courses in pharmacology and toxicology, public health and European institutions.
Estonian: Haridus: Lõpetanud Barcelona Ülikooli farmatseudina ja kraadiga meditsiini ja kirurgia alal, samuti täiendõppe farmakoloogia ja toksikoloogia, rahvatervise ja Euroopa institutsioonide alal.
English: The new scope encompasses medicines intended for self-medication, generic products of centrally authorised medicinal products, and biosimilar medicinal products.
Estonian: Nende hulka kuuluvad iseravimiseks ette nähtud ravimid, tsentraliseeritud müügiloaga ravimite geneerilised variandid ja bioloogiliselt sarnased ravimid.
English: In 1984, he joined the Veterinary Medicines Laboratory in Fougères where he was assessor and rapporteur for marketing authorisation dossiers.
Estonian: 1984. aastal asus ta tööle Fougères'i Veterinaarravimite Laboratooriumi hindajana ja müügiloataotluste ettekandjana.
English: o the format and content of the bibliographic review of safety data and expert report required as part of the documentation supporting an application for registration o the bibliography or expert evidence on the medicinal use throughout a period of at least 30 years (format and type of evidence) to support a registration application o demonstration that the pharmacological effects or the efficacy are made plausible on the basis of long-standing use and experience
Estonian: o registreerimistaotlusele lisatavate dokumentide seas nõutavate ohutusandmete bibliograafilise ülevaate ja ekspertiisiaruande vorm ja sisu; o registreerimistaotlusele lisatud bibliograafia või ekspertiisitõendid meditsiinilise kasutamise kohta vähemalt 30 aasta jooksul (tõendi vorm ja liik);
English: Revision to be released for public consultation by April 2005
Estonian: Muudatused suunatakse avalikule arutelule 2005. aasta aprilliks
English: Other documents on working practices and work-sharing as well as new document management and communication/information exchange/tracking tools, in particular
Estonian: Other documents on working practices and work-sharing as well as new document management and communication/information exchange/tracking tools, in particular with view to implementing the EU Risk Management Strategy and the revised PhVWP Mandate of September 2003
English: 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea.eu.int http://www.emea.eu.int
Estonian: 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Faks (44-20) 74 18 84 09
English: From 1984 to 1994, as medical director at the pharmaceutical department of the Italian Ministry of Health, she was in charge of the Operative Centre for Community Procedures, was the Italian member of the former Committee for Proprietary Medicinal Products (CPMP), and was also involved in ICH activities.
Estonian: Itaalia Tervishoiuministeeriumi farmaatsiaosakonna meditsiinidirektorina, mil talle allus Euroopa ühenduse menetluste operatiivkeskus, ning ta oli endise ravimpreparaatide komitee Itaalia-poolne liige, kes osales ka ICH tegevustes.
English: The CVMP will meet 11 times during the year.
Estonian: Veterinaarravimite komitee koosolekud toimuvad 11 korda aastas.
English: Patrick Le Courtois, Head of Unit, b. 9 August 1950, n. French
Estonian: Patrick Le Courtois, üksuse juhataja, sünd.
English: Management Board meetings in 2005
Estonian: Haldusnõukogu koosolekud 2005. aastal
English: Provision of dedicated and up-to-date information on procedures for emerging therapies and technologies
Estonian: põhjalike ja värskete andmete esitamine uute raviviiside ja tehnoloogiate suhtes kohaldatavate menetluste kohta;
English: Establishment of a dedicated sector for medical information
Estonian: spetsiaalse meditsiinilise teabe sektori moodustamine;
English: Visitors to the Agency
Estonian: Ameti külastajad
English: Integrated quality management IQM adviser
Estonian: Integreeritud kvaliteedijuhtimine Integreeritud kvaliteedijuhtimise nõunik
English: Postgraduate qualifications in internal medicine, endocrinology, diabetology and cardiology.
Estonian: Täiendõpe sisehaiguste, endokrinoloogia, diabetoloogia ja kardioloogia alal.
English: Postgraduate qualifications in paediatrics and methodology.
Estonian: Täiendõppes omandatud kvalifikatsioon pediaatrias ja metoodikas.
English: The legislation places emphasis on transparency, communication and provision of information on pharmacovigilance issues.
Estonian: Õigusaktides rõhutatakse ravimiohutuse järelevalve alase teabe läbipaistvust, kommunikatsiooni ja teavitamist.
English: Efficacy Working Party
Estonian: Efektiivsuse töörühm
English: Miss Leivers joined the EMEA in February 1996 and was appointed deputy head of sector in June 2001.
Estonian: Pr Leivers asus tööle EMEA-s 1996. aasta veebruaris ja määrati 2001. aasta juunis sektori juhataja asetäitjaks.
English: Career to date: From 1977 to 1986, Dr Le Courtois worked as a general practitioner and as director of a medical centre in Paris.
Estonian: Senine teenistuskäik: Aastail 1977-1986 töötas dr Le Courtois Pariisis üldarstina ja meditsiinikeskuse direktorina.
English: Ms Fayl joined the EMEA in April 1995.
Estonian: Pr Fayl asus EMEA-s tööle 1995. aasta aprillis.
English: Service quality will be measured by a number of performance indicators, such as systems availability, helpdesk response times and problem resolution times
Estonian: Teenuse kvaliteeti mõõdetakse selliste tegevuse tulemuste näitajatega nagu süsteemide kättesaadavus, kasutajatoe reageerimiskiirus ja probleemide lahendamise kiirus;
English: 10-12 May
Estonian: 10.-12. mai
English: Education: Diploma in conference interpretation and translation from Scuola Superiore per Interpreti, Milan.
Estonian: Haridus: Milano Scuola Superiore per Interpreti diplom konverentsitõlke ja kirjaliku tõlke alal.
English: Adequate implementation of the concept of risk management plans
Estonian: Need algatused hõlmavad riskijuhtimiskavade kontseptsiooni rakendamist,
English: Specialist in endocrinology and metabolic diseases.
Estonian: Spetsialist endokrinoloogia ja ainevahetushaiguste alal.
English: The target is 90 % of summaries published at the time of the press release o percentage of European public assessment reports published within two weeks after Commission decision.
Estonian: Sihiks on 90% kokkuvõtete avaldamine samal ajal pressiteatega; o Euroopa avalike hindamisaruannete hulk, mis on avaldatud kahe nädala jooksul alates komisjoni otsusest.
English: Executive master of business administration from the Centre de Perfectionnement aux Affaires at HEC-CPA, in Jouy-en-Josas, France, in 2000.
Estonian: 1961, prantslane Haridus: Pariisis Institut Superieur de Gestionis kaitstud magistrikraad ärijuhtimise alal, samuti asutuse HEC-CPA Centre de Perfectionnement aux Affaires ärijuhtimise magistrikraad, Prantsusmaa, Jouy-en-Josas, 2000.
English: Prepare for the submission of applications for biosimilar, generic and self-medication medicinal products
Estonian: valmistumine taotluste esitamiseks bioloogiliselt sarnaste, geneeriliste ja iseravimiseks mõeldud ravimite kohta;
English: The forecast for electronic reporting for non-centrally authorised products in relation to EU and non-EU cases is 15,000
Estonian: prognooside kohaselt esitatakse tsentraliseeritud menetluse väliselt müügiloa saanud ravimite aruandeid Euroopa Liidust ja väljastpoolt elektrooniliselt 15 000;
English: Jill Ashley-Smith, Head of Sector for veterinary marketing authorisation procedures, b. 18 December 1962, n. British
Estonian: Jill Ashley-Smith, veterinaarravimite müügilubade korra sektori juhataja, sünd.
English: Electronic reporting of Adverse Drug Reactions for all veterinary medicines will be initiated under EudraVigilance Veterinary on 1 January 2005
Estonian: EudraVigilance Veterinary andmebaasis käivitatakse alates 1. jaanuarist 2005 kõigi veterinaarravimite kõrvaltoimete elektrooniline aruandlus;
English: To increase the quality and the regulatory and scientific consistency of the evaluation of applications for line extensions, variations to and transfers of marketing authorisations, and adhere to regulatory timelines
Estonian: tooterühma laiendamise, müügilubade muutmise ja ülekandmise taotluste hindamise kvaliteedi ja õigusliku ning teadusliku järjekindluse suurendamine ja kehtestatud tähtaegadest kinnipidamine.
English: Career to date: From 1977 to 1990, Professor Torrent i Farnell worked in internal medicine and clinical pharmacology in Spain and was assistant professor of pharmacology at the UAB.
Estonian: Senine teenistuskäik: Aastail 1977-1990 töötas prof. Torrent i Farnell Hispaanias sisehaiguste ja kliinilise farmakoloogia alal ja oli UAB farmakoloogia dotsent.
English: The initial evaluation phase covers a number of EMEA activities ranging from pre-submission discussions with future applicants, through the evaluation by the CVMP, to the granting by the European Commission of the product marketing authorisation.
Estonian: Algse hindamise etapp hõlmab mitmeid EMEA tegevusi alates taotluse esitamiseelsetest aruteludest tulevaste taotlejatega kuni hindamiseni veterinaarravimite komitees ja ravimile Euroopa Komisjoni poolt müügiloa andmiseni.
English: Tony Humphreys, Head of Sector for regulatory affairs and organisational support, b. 12 December 1961, n. Irish
Estonian: Tony Humphreys, regulatiivküsimuste ja organisatoorse abi sektori juhataja, sünd.
English: To this end, the CHMP has already established a Scientific Advice Working Party (SAWP) that has the sole remit of providing scientific advice to undertakings.
Estonian: Selleks on inimtervishoius kasutatavate ravimite komitee moodustanud juba teadusnõustamise töörühma, mille ainus tegevusala on äriühingute teadusnõustamine.
English: Coordinate and manage effectively the requests for GMP, GCP, pharmacovigilance and GLP inspections relating to applications for products through the centralised procedure within the timeframe laid down in Community law and to the standards required by the Agency's quality management system
Estonian: Hea tootmistava, hea kliinilise tava, ravimiohutuse järelevalve ja hea laboritava kontrollimise taotluste koordineerimine ja tõhus haldamine seoses tsentraliseeritud menetluse kaudu esitatud ravimitaotlustega ühenduse õigusaktides esitatud tähtaegade jooksul ja ameti kvaliteedijuhtimissüsteemis nõutud standardite kohaselt.
English: Career to date: From 1973 to 1979, Professor Wahlroos served as a pharmacist and a researcher in several pharmacies, at the University of Helsinki and in the pharmaceutical industry.
Estonian: Senine teenistuskäik: Aastail 1973-1979 töötas prof. Wahlroos farmatseudi ja teadurina mitmes apteegis, Helsingi Ülikoolis ja farmaatsiaettevõtetes.
English: Board-certified specialist in pharmacology and toxicology (Bavarian Chamber of Physicians).
Estonian: Nõukogu poolt sertifitseeritud spetsialist farmakoloogia ja toksikoloogia alal (Baieri Arstide Koda).
English: Ensure high-quality functioning of core activities through effective management of the increasing workload and adherence to reduced regulatory timelines for pre and post-authorisation activities
Estonian: põhitegevuste kvaliteetse toimimise tagamine, hallates tõhusalt kasvavat töökoormust ja pidades kinni müügiloa andmise eelsete ja järgsete regulatiivtegevuste lühendatud tähtaegadest; elutsükli juhtimise ja teadusliku järjekindluse kontseptsiooni tugevdamine;
English: The goal is to shorten the procedure time for safety referrals
Estonian: Sihiks on lühendada lahendamiseks suunatud ohutusküsimuste esildiste menetlemise aega;
English: Trends:
Estonian: Suundumused:
English: For product defect and other quality-related matters E-mail: qualitydefects@emea.eu.int Fax: (44-20) 74 18 85 90
Estonian: Ravimite puudused ja muud kvaliteediküsimused E-post: qualitydefects@emea.eu.int Faks: (44-20) 74 18 85 90
English: He acted as senior pharmaceutical consultant for the Swedish health cooperation programme in Vietnam from 1982 to 1994.
Estonian: Aastail 1982-1994 töötas ta Vietnamis Rootsi tervishoiualase koostööprogrammi vanemkonsultandina farmaatsia alal.
English: 17-19 May
Estonian: 17.-19. mai
English: Protocol assistance and follow-up finalised Scientific advice and follow-up finalised
Estonian: Protseduuriline abi ja järeltoimingud Teadusnõuanded ja järeltoimingud
English: Preparation of EPAR summaries that are written so they are understandable to the public, and coordination with applicants to ensure package leaflets are similarly written in a manner comprehensible to the lay person
Estonian: Euroopa avalike hindamisaruannete koostamine üldsusele arusaadaval viisil ja koordineerimine taotlejatega, et pakendi infolehed oleksid samuti koostatud mittespetsialistile arusaadavalt.
English: PhD in pharmaceutical microbiology from the University of Strathclyde, Glasgow.
Estonian: PhD farmatseutilise mikrobioloogia alal Glasgow Strathclyde'i Ülikoolist.
English: Career to date: From 1976 to 1986, Dr Brasseur worked as a paediatrician at the University Sint Pieter Hospital in Brussels.
Estonian: Senine teenistuskäik: Aastail 1976-1986 töötas dr Brasseur pediaatrina Brüsselis Sint Pieteri Ülikooli
English: Agnès Saint Raymond, Head of Sector for orphan drugs and scientific advice and Acting Head of Sector for safety & efficacy of medicines, b. 7 September 1956, n. French
Estonian: Agnès Saint Raymond, harva kasutatavate ravimite ja teadusliku nõustamise sektori juhataja ja ravimite ohutuse ja efektiivsuse sektori juhataja kohusetäitja, sünd.
English: In 1997, he was appointed head of the pharmaceuticals assessment unit of the French veterinary agency (AFSSA-ANMV).
Estonian: Veterinaariaameti farmaatsiatoodete hindamise (AFSSA-ANMV) üksuse juhatajaks.
English: Postgraduate studies in cardiology and endocrinology.
Estonian: Täiendõpe kardioloogia ja endokrinoloogia alal.
English: 18-21 April
Estonian: 18.-21. aprill
English: 23-26 May
Estonian: 23.-26. mai
English: The performance indicator for this objective is the percentage of applications evaluated within the 30, 60 or 90-day timeline (depending on the procedure).
Estonian: Selle eesmärgi saavutamise näitaja on 30-, 60- või 90-päevase tähtaja jooksul hinnatud taotluste arv (olenevalt menetlusest).
English: Need for comments in the light of experience to be considered in 2005
Estonian: 2005. aastal kaalutakse kogemuste põhjal märkuste vajadust